☆ 4.5 Letter

COVID-19 in Parkinson's disease: Report on prevalence and outcome

PARKINSONISM & RELATED DISORDERS (2020)

Get Full Text
Add to Collection

Journal

PARKINSONISM & RELATED DISORDERS
Volume 80, Issue -, Pages 7-9

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2020.09.008

Keywords

Parkinson's disease; COVID-19; Infection

Categories

Clinical Neurology

Funding

  1. Zambon
  2. Abbvie
  3. Ralpharma
  4. Neuraxpharm
  5. Lusofarmaco
  6. Chiesi Farmaceutici
  7. Medtronic
  8. UCB Pharma

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.